Holen Sie sich die Stockscreener-App
26.38
0.65%
0.1673
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Bio Usawa Appoints Dr. Aida Habtezion, Former Chief Medical Officer at Pfizer, to its Board of Directors - GlobeNewswire
SINOPHARM (01099.HK) Establishes Strategic Partnership with Pfizer, Inc. (PFE.US) - AASTOCKS.com
Pfizer Obesity Pipeline Gains Traction As Berobenatide Data Support Valuation - Yahoo Finance
Pfizer Holds Near $26, Dividend Draws Watch as Drug Prices Cloud Outlook - TechStock²
Comirnaty (Original/Omicron XBB.1.5): Updated mRNA COVID-19 vaccine in focus for US adults - AD HOC NEWS
Pfizer Inc. Stock (US7170811035): Analyst Views and Valuation Under the Microscope - AD HOC NEWS
Pfizer (PFE) Upgraded at RBC Capital. Here is Why - Insider Monkey
How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take. - The Motley Fool
Pfizer trades around $26 with dividend in focus, drug-price worries linger - TechStock²
Pfizer Pivots Hard: Obesity, Cancer Bets Tempt Investors - TipRanks
Insider trades: Microsoft, Tesla, Pfizer among notable names - Seeking Alpha
Pfizer (PFE): The Best Longevity Stock to Buy Now - Insider Monkey
Pfizer Draws Fresh Focus As Growth Strategy Evolves - Kalkine Media
Pfizer (PFE) Stock Valuation Check As Modest Recent Gains Meet Mixed Multi Year Returns - simplywall.st
Dividend HistoryPfizer (PFE) - Zacks Investment Research
Pfizer Draws Fresh Attention As Pipeline Activity Accelerates - Kalkine Media
Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About - Yahoo Finance
Pfizer Still Trades Over $26 as RBC Lift Balances Out Drug-Pricing Concerns - TechStock²
ORIC gains as Stifel resumes at Buy on upcoming Pfizer readout - Seeking Alpha
SpaceX IPO: Value Investors Warn You're Buying A StoryPfizer (NYSE:PFE), SpaceX (NASDAQ:SPCX) - Benzinga
Pfizer Oncology Data Underscore Survival Gains And Valuation Debate - Yahoo Finance
US legislation targets China pharma IP licensing following multi-billion Pfizer, BMS deals - IAM Patent
Pfizer Inc. $PFE Shares Bought by Xponance LLC - MarketBeat
Pfizer Inc. $PFE Stake Lowered by Swiss National Bank - MarketBeat
Pfizer Inc. $PFE Shares Sold by Te Ahumairangi Investment Management Ltd - MarketBeat
Kovack Advisors Inc. Buys 64,044 Shares of Pfizer Inc. $PFE - MarketBeat
ICICI Prudential Asset Management Co Ltd Has $4.11 Million Stock Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Purchased by IFM Investors Pty Ltd - MarketBeat
Alps Advisors Inc. Sells 57,526 Shares of Pfizer Inc. $PFE - MarketBeat
First Financial Bankshares Inc Sells 54,776 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Purchased by Aviva PLC - MarketBeat
Pfizer Inc. (NYSE:PFE) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Does New GLP‑1 Data And HYMPAVZI Expansion Reshape The Bull Case For Pfizer (PFE)? - simplywall.st
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Pfizer (NYSE:PFE) Shares Up 2.2%Here's What Happened - MarketBeat
Pfizer Inc. stock outperforms competitors on strong trading day - MarketWatch
PFE Stock Quote Price and Forecast - CNN
This $25 Billion Acquisition Just Unlocked a New Era of Growth for Pfizer — and Why It’s a Flawless Safe-Haven for Retirees - Yahoo Finance
A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25 - Yahoo Finance
Pfizer’s New Phase 1 PF-07799544 Study Adds Quiet Depth to Its R&D Pipeline - TipRanks
Why Pfizer Stock Popped Today - The Globe and Mail
Pfizer Shares Edge Higher on RBC Upgrade, German Pricing Risk in Focus - TechStock²
Lexicon Pharmaceuticals vs Pfizer: Comparing a Small Biotech with a Global DrugmakerNews and Statistics - IndexBox
Pfizer shares climb 3.2% as investors digest expanded U.S. label for HYMPAVZI - Quiver Quantitative
Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026? - Yahoo Finance
Pfizer Inc. $PFE Stock Position Lowered by Townsquare Capital LLC - MarketBeat
Insider Sell: Jennifer Damico Sells 2,000 Shares of Pfizer Inc (PFE) - GuruFocus
Veteran Analyst Revamps Pfizer Stock Price Target for Rest of 2026 - TradingView
Roche and Pfizer race to lead obesity and diabetes drug market with promising new treatments. - Pluang
Roche Vs. Pfizer: Obesity Week Presentations Deep DiveWhat Investors Must Know (RHHBY) - Seeking Alpha
Pfizer Steps Up in Obesity Race With New Mid-Stage SOLIS-1 Trial - TipRanks
Pfizer pulls out of summit with Germany's Merz over health care reform - Yahoo Finance
Pfizer CEO warns German investment at risk over drug pricing policies - Reuters
Pfizer's 2025 Impact Report Highlights Progress Across Patients, Planet, and Responsible Business - Pfizer
Pfizer Stock 2026: CEO Lays Out the Case for a Growth Surge - TIKR.com
Pfizer upgraded at RBC Capital Markets on risk-reward setup - MSN
Pfizer stock upgraded at RBC Capital Markets (PFE:NYSE) - Seeking Alpha
Wills Financial Group LLC Increases Stake in Pfizer Inc. $PFE - MarketBeat
Letko Brosseau & Associates Inc. Sells 160,000 Shares of Pfizer Inc. $PFE - MarketBeat
Analyst recommendations: Nike, Pfizer, Hewlett Packard, Intel, The Trade Desk… - marketscreener.com
RBC Upgrades Pfizer to Sector Perform from Underperform, PT is $25 - marketscreener.com
Deutsche Bank AG Has $769.38 Million Stock Holdings in Pfizer Inc. $PFE - MarketBeat
FDA Approval for HYMPAVZI issued to PFIZER INC - Quantisnow
Cerity Partners LLC Buys 1,448,806 Shares of Pfizer Inc. $PFE - MarketBeat
RBC Capital upgrades Pfizer stock rating on valuation - Investing.com
1.70%
0.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):